🇺🇸 FDA
Pipeline program

ORMD-0801

ORMD-0801-KHUH

Phase 3 small_molecule active

Quick answer

ORMD-0801 for Diabetes Mellitus, Type 2 is a Phase 3 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
ORAMED PHARMACEUTICALS INC.
Indication
Diabetes Mellitus, Type 2
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials